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creativecommons.org/licenses/by-nc-Abstract To avoid abuse of fine-needle aspiration cytology (FNAC) and to save the time of a
learning curve, a computer-aided detection and diagnosis (CAD) system to detect suspicious
lesions for FNAC from thyroid ultrasonography has been developed by the Department of Indus-
trial Engineering, cooperative with the Department of Surgery at the National Taiwan Univer-
sity, Taipei, Taiwan. The purposes of this article are to introduce how to utilize the CAD system
in thyroid ultrasonography, and to outline the real role of the CAD system. After marking the
apparently transverse (extending across) axis and longitudinal axis of the nodule appearing by
ultrasonography, four parameters are calculated and displayed by the computer system auto-
matically, which include microcalcifications, hypoechoic lesion, heterogeneity, and indistinct
margin. The results are displayed by the pointers in the semilunar figures. The necessity of
FNAC is dependent on the size and numbers of positive findings (pointers displayed in the right
side). This CAD system is objective and easy to use. It may supply an easy method to determine
the necessity for FNAC, but what we must keep in mind is that this method can reduce the ne-
cessity of FNAC, not replace FNAC for the diagnosis of thyroid cancer.
ª 2015, Chinese Taipei Society of Ultrasound in Medicine. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).s never been involved in any funded projects developing the CAD device. All the figures are supplied
Therefore, readers must be careful to judge the feasibility of the method described in this article.
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The number of cases of thyroid cancer have the trend of
increasing gradually in many countries, including the United
States [1] and Taiwan [2,3], although the increase in mor-
tality is not noted. The dramatic increase in the number of
thyroid cancer cases is considered to be related to many
factors, but increased screening by ultrasonography may be
the most important factor [1]. However, the increased
incidence across all tumor sizes suggests that increased
diagnostic scrutiny is not the only reason [1].
Although it is cheap to carry out fine-needle aspiration
cytology (FNAC) in Taiwan, especially under the coverage ofFigure 1 (A) Locate the first point in the left border of the thyroi
the right border with the largest diameter of the lesion. Locate th
thyroid nodule, then draw to the middle part in the lower border
Figure 2 For the longitudinal axis, locate the second point at
the middle part in the upper border of the thyroid nodule, then
draw to the middle part in the lower border of the thyroid
nodule.health insurance, the work-load would delay the further
work-up and management of patients if every case sus-
pected to have thyroid nodule was to be aspirated and read
after staining to judge whether it is malignant or not.
In the study reported by Bonavita et al [4], there are
several patterns shown by thyroid ultrasonography which
are indicative of benignancy, and further FNAC is not
necessary. These include spongiform configuration, cysts
with colloid clots, giraffe pattern, and diffuse hyper-
echogenicity. The specificity is 100%. They estimated 60% of
FNAC procedures could be saved. Different patterns on
thyroid ultrasonograms between benign and malignant le-
sions have also been stressed [5].d lesion with the largest diameter. (B) Draw to extend across to
e second point of the middle part in the upper border of the
of the thyroid nodule.
Figure 3 As soon as the two axes are defined, the contour is
automatically generated by the computer-aided detection and
diagnosis system.
Figure 4 Users can choose to fine-tune the contour by adding
an additional marker, followed by clicking and dragging it.
Figure 5 The thyroid lesion is< 1 cm in diameter; fine-
needle aspiration cytology needs to be performed.
Figure 6 The thyroid lesion from Figure 5. Parameter 1 (microcal
computer-aided detection and diagnosis system are both positive.
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It is not easy to read ultrasonography accurately for the
beginner, and the diagnosis by cytology is even more diffi-
cult. Both of them need a so-called learning curve. Accu-
mulation of experience can conquer this problem.
However, at the initial stage, this problem can be solved by
the coverage of senior doctors. Although this is a formal
way of learning medical knowledge, it is better to have a
faster and objective way to solve this problem in the image
system.Computer-aided detection or computer-aided
diagnosis
According to the recently published Food and Drug Admin-
istration (FDA) guidance [6], computer-aided detection
(CADe) devices are computerized systems intended to
identify, mark, highlight, or in any other manner direct
attention to portions of an image, or aspects of radiology
device data, that may reveal specific abnormalities during
interpretation of patient radiology images or patient radi-
ology device data by the clinician, while the computer-
aided diagnosis (CADx) devices include those that are
intended to provide an assessment of disease or other
conditions in terms of the likelihood of the presence or
absence of disease, or are intended to specify disease type
(i.e., specific diagnosis or differential diagnosis), severity,
stage, or intervention recommended. The method
mentioned in this article therefore includes both CADe and
CADx (CAD).
To differentiate benign from malignant thyroid lesions
automatically in order to avoid the need of a learning
curve and to save working time, a review of CAD of thyroid
nodule in thyroid ultrasonography was published [7]. The
authors showed that the features can be categorized into
(1) the sonographic features from the ultrasound images,
and (2) the nonclinical features extracted from the ul-
trasound images using statistical and data mining
techniques.cification) and Parameter 2 (hypoechogenicity) detected by the
Figure 7 The thyroid lesion is< 1 cm in diameter; follow-up
only is required.
Figure 9 Thyroid lesions 1e1.5 cm in diameter, for which
fine-needle aspiration cytology needs to be performed.
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With the cooperation of experts from the Department of
Industrial Engineering and the Department of Surgery, Na-
tional Taiwan University, Taipei, Taiwan, a CAD for thyroid
nodule was developed successfully, and obtained the pat-
ents from the FDA of the United States [8,9], Taiwan
[10e12], China [13], Malaysia [14], and Singapore [15,16].
They proved that the new CAD method is more sensitive and
more objective than traditional observation of ultrasonog-
raphy in the detection and quantification of micro-
calcifications [17]. This method is also correlated with
conventional ultrasonic heterogeneity assessment, but can
be a better aid in the diagnosis of thyroid malignancy [18].Figure 8 The thyroid lesion from Figure 7. Parameter 1 (microcal
computer-aided detection and diagnosis system are both negativeHow to perform CAD
It is simple to perform the CAD invented in Taiwan. The first
point in the left border of the thyroid lesion with the largest
diameter (Figure 1) is located, then drawn to extend across
the lesion to the right border with the largest diameter of
the lesion. For the longitudinal axis, the second point at the
middle part in the upper border of the thyroid nodule is
located, and then drawn to the middle part in the lower
border of the thyroid nodule (Figure 2). Then the margin is
shaped automatically (Figure 3). If users are not satisfied
with the initial contour generated automatically, the
selected marker that the observer wants to move can be
selected and dragged to a new location. Release of the
mouse button sets the contour shape. Therefore, users can
fine-tune the contour by adding additional markers to thecification) and Parameter 2 (hypoechogenicity) detected by the
.
Figure 10 The thyroid lesion from Figure 9. Either Parameter 1 (microcalcification) or Parameter 2 (hypoechogenicity) detected
by the computer-aided detection and diagnosis system is positive.
Figure 11 Thyroid lesions 1e1.5 cm in diameter which need
follow-up only.
Figure 12 Thyroid lesion from Figure 11. Both Parameter 1 (micro
the computer-aided detection and diagnosis system are negative.
CAD in Thyroid Lesion Differential Diagnosis 181contour and moving their position (Figure 4). Then the
severity of the parameters are calculated and displayed by
the computer system automatically, which include micro-
calcification, hypoechoic lesion, heterogeneity, and indis-
tinct margin. The results are displayed by the pointers in
the semilunar figures. The necessity of FNAC is dependent
on the size and number of positive findings (pointers dis-
played on the right hand side) according to the guideline of
the American Thyroid Association for differentiated thyroid
cancer [19].
Figures 5 and 6 represent the example of thyroid
lesions< 1 cm in diameter, for which FNAC needed to be
performed because Parameter 1 (microcalcification) and
Parameter 2 (hypoechogenicity) detected by the CAD were
both positive.
Figures 7 and 8 represent the example of thyroid
lesions< 1 cm in diameter which needed follow-up only
because Parameter 1 and Parameter 2 detected by the CAD
were both negative.calcification) and Parameter 2 (hypoechogenicity) detected by
Figure 13 The thyroid lesion is> 1.5 cm in diameter, which
needs fine-needle aspiration cytology.
Figure 15 Thyroid lesions> 1.5 cm in diameter, which need
follow-up only.
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sions 1e1.5 cm in diameter, for which FNAC needed to be
performed because either Parameter 1 or Parameter 2
detected by the CAD is positive.
Figures 11 and 12 represent the example of thyroid le-
sions 1e1.5 cm in diameter which needed follow-up only
because both Parameter 1 and Parameter 2 detected by the
CAD are negative.
Figures 13 and 14 represent the example of thyroid
lesions> 1.5 cm in diameter which need FNAC because of
the presence of any one of Parameters 1e4 found by the
CAD.
Figures 15 and 16 represent the example of thyroid
lesions> 1.5 cm in diameter, which need follow-up only
because Parameters 1e4 detected by the CAD are all
negative.
These examples show that for small lesions (< 1 cm in
diameter), both Parameter 1 (microcalcification) and
Parameter 2 (hypoechogenicity) need to be positive, and
then FNAC is required. If there is a lesion with diameter
from 1 cm to 1.5 cm, either microcalcification or hypo-
echogenicity need to be positive. However, if the lesionFigure 14 Thyroid lesion from Figure 13. The presence of any
heterogenicity, and blurred margin) detected by the computer-aiddetected by thyroid ultrasonography is> 1.5 cm in diam-
eter, then any one of four parameters (microcalcification,
hypoechoic lesion, heterogeneity, and indistinct margin)
being positive is enough for the necessity of FNAC. There-
fore, the necessity of FNAC depends on size and items of
positive finding. Microcalcification and hypoechoic lesion
are more important than heterogeneity and indistinct
margin in this system for small thyroid lesion (< 1 cm in
diameter).CAD cannot replace FNAC
This CAD system is objective and easy to use. It may supply
an easy method to determine the necessity for FNAC, but
what we must keep in mind is that while this method can
reduce the necessity of FNAC, it cannot replace FNAC in the
diagnosis of thyroid cancer as many people believe.one of Parameters 1e4 (microcalcification, hypoechogenicity,
ed detection and diagnosis system.
Figure 16 Thyroid lesion from Figure 15. Parameters 1e4, detected by the computer-aided detection and diagnosis system, are
all negative.
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FNAC at the time with CAD
Using the CAD system, the necessity for performing FNAC
can be determined. If the lesion is not easily located, it is
better under ultrasonography-guidance [20]. The method of
further management may be further planned with the help
of cytomorphology [21] or molecular determination [22].Conclusion
CAD is an objective way to determine which thyroid nodules
need to have FNAC. It saves workload, and there is no
interobserver variation. However, no examination is per-
fect, which also includes CAD of the thyroid nodule.
Therefore, follow-up is necessary if the thyroid lesions are
considered not to require FNAC by CAD. It is important to
follow this rule to avoid the legal problems which may occur
if CAD predicts the lesion does not require FNAC, but the
lesion ultimately is malignant.Acknowledgments
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